A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell
A phase 3 trial of Odronextamab, Ifosfamide, Carboplatin in hodgkin lymphoma and non-hodgkin lymphoma, run by Regeneron Pharmaceuticals, active and no longer recruiting.
Overview
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma is a phase 3 interventional study registered as NCT06230224 by Regeneron Pharmaceuticals, with 216 participants enrolled, started 2024-02-15 and due to reach its primary completion in 2028-05-29. Interventions recorded: Odronextamab, Ifosfamide, Carboplatin, Etoposide, Rituximab. Conditions listed: B-Cell Non-Hodgkin Lymphoma (B-NHL). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treat
Shares Odronextamab, Regeneron, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TrialA Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Matu
Shares Ifosfamide, Etoposide, Rituximab, Non-Hodgkin lymphoma (all types).
- TrialA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participant
Shares Odronextamab, Regeneron, Rituximab.
- TrialA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Pa
Shares Odronextamab, Regeneron, Rituximab.
- TrialA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy
Shares Odronextamab, Regeneron, Rituximab.
- TrialA Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemo
Shares Odronextamab, Regeneron, Rituximab.
- TrialStudy of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma
Shares Rituximab, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TrialTIGER: standard-dose TIP versus high-dose TI-CE with stem cell transplant as first salvage for relapsed germ cell tumours
Shares Ifosfamide, Etoposide, Carboplatin.